Pfizer Pulls Hypertension Drug Thelin From Market
Pfizer Inc. said Friday that it would withdraw its pulmonary arterial hypertension treatment Thelin from the marketplace and discontinue clinical studies of the drug, which has been at the center of...To view the full article, register now.
Already a subscriber? Click here to view full article